Designer drugs in herbal aphrodisiacs

Forensic Science International

Volumn 177, Issue 2-3, 2008, Pages

  Venhuis, Bastiaan J ^a   Blok Tip, Leonore ^a   de Kaste, Dries ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Analogs; Designer drug; Herbal; Sildenafil; Vardenafil; Viagra

Indexed keywords

ACETILDENAFIL; APHRODISIAC AGENT; DESIGNER DRUG; ETHYLSILDENAFIL; HERBACEOUS AGENT; HYDROXYETHYLSILDENAFIL; LIBIDFIT; PHOSPHODIESTERASE V INHIBITOR; SATIBO; SILDENAFIL; UNCLASSIFIED DRUG; VARDENAFIL; VIAMAX;

ARTICLE; DIODE; DRUG DETERMINATION; DRUG MARKETING; DRUG POTENCY; DRUG SAFETY; ERECTILE DYSFUNCTION; HEALTH HAZARD; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 41649092477     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.forsciint.2007.11.007     Document Type: Article

References (24)

1. Fleshner N., Harvey M., Adomat H., Wood C., Eberding A., Hersey K., and Guns E. Evidence for contamination of herbal erectile dysfunction products with phosphodiesterase type 5 inhibitors. J. Urol. 174 (2005) 636-641 (discussion 641; quiz 801)
2. L. Blok-Tip, H. Vogelpoel, M.J. Vredenbregt, D.M. Barends, D. de Kaste, Counterfeits and imitations of Viagra and Cialis tablets: trends and risks to public health-A survey of the analyses carried out at the Dutch National Institute for Public Health and the Environment in the time period 2000-2004, RIVM rapport 267041001 2005, National Institute for Public Health and the Environment.
3. B.J. Venhuis, D.M. Barends, M.E. Zwaagstra, D. de Kaste, Recent developments in counterfeits and imitations of Viagra, Cialis and Levitra, A 2005-2006 update, RIVM Report 370030001/2007, 2007, National Institute for Public Health and the Environment.
4. Dumestre-Toulet V., Cirimele V., Gromb S., Belooussoff T., Lavault D., Ludes B., and Kintz P. Last performance with VIAGRA: post-mortem identification of sildenafil and its metabolites in biological specimens including hair sample. Forensic Sci. Int. 126 (2002) 71-76
5. Blok-Tip L., Zomer B., Bakker F., Hartog K.D., Hamzink M., Ten Hove J., Vredenbregt M., and De Kaste D. Structure elucidation of sildenafil analogues in herbal products. Food Addit. Contam. 21 (2004) 737-748
6. Reepmeyer J.C., and Woodruff J.T. Use of liquid chromatography-mass spectrometry and a hydrolytic technique for the detection and structure elucidation of a novel synthetic vardenafil designer drug added illegally to a "natural" herbal dietary supplement. J. Chromatogr. A. 1125 (2006) 67-75
7. Shin C., Hong M., Kim D., and Lim Y. Structure determination of a sildenafil analogue contained in commercial herb drinks. Magn. Reson. Chem. 42 (2004) 1060-1062
8. Shin M.H., Hong M.K., Kim W.S., Lee Y.J., and Jeoung Y.C. Identification of a new analogue of sildenafil added illegally to a functional food marketed for penile erectile dysfunction. Food Addit. Contam. 20 (2003) 793-796
9. Weishaar R.E., Burrows S.D., Kobylarz D.C., Quade M.M., and Evans D.B. Multiple molecular forms of cyclic nucleotide phosphodiesterase in cardiac and smooth muscle and in platelets. Isolation, characterization, and effects of various reference phosphodiesterase inhibitors and cardiotonic agents. Biochem. Pharmacol. 35 (1986) 787-800
10. Pissarnitski D. Phosphodiesterase 5 (PDE 5) inhibitors for the treatment of male erectile disorder: attaining selectivity versus PDE6. Med. Res. Rev. 26 (2006) 369-395
11. Wang J., Jiang Y., Wang Y., Zhao X., Cui Y., and Gu J. Liquid chromatography tandem mass spectrometry assay to determine the pharmacokinetics of aildenafil in human plasma. J. Pharm. Biomed. Anal. 44 (2007) 231-235
12. Saenz de Tejada I., Angulo J., Cuevas P., Fernandez A., Moncada I., Allona A., Lledo E., Korschen H.G., Niewohner U., Haning H., Pages E., and Bischoff E. The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil. Int. J. Impot. Res. 13 (2001) 282-290
13. Campbell S.F. Science, art and drug discovery: a personal perspective. Clin. Sci. (Lond.) 99 (2000) 255-260
14. Poon W.T., Lam Y.H., Lai C.K., Chan A.Y., and Mak T.W. Analogues of erectile dysfunction drugs: an under-recognised threat. Hong Kong Med. J. 13 (2007) 359-363
15. M.W. Orme, J.S. Sawyer, L.M. Schultze, inventors, Lilly-ICOS-LLC, assignee. Tetracyclic compounds as PDE-5 inhibitors, Patent WO02/098428 (2002).
16. U. Niewöhner, M. Es-Sayed, H. Haning, T. Schenke, G. Schmidt, K.H. Schlemmer, E. Bischoff, K. Dembowski, E. Perzborn, inventors, Bayer-Aktiengesellschaft, assignee. 7-Alkyl- and cycloalkyl-substituted imidazotriazinones, Patent WO99/67244 (1999).
17. P. Ellis, N.K. Terrett, inventors, Pfizer-Research-and-Development-Company, assignee. Pyralozopyrimidones for the treatment of impotence, Patent WO94/28902 (1994).
18. WADA, The World Anti-Doping Code, The 2007 Prohibited List, International Standard (September 16, 2006).
19. Libidfit court case, LJN: BA4929, No. 12/035253-04, Rechtbank Middelburg, The Netherlands at April 25, 2007, http://www.rechtspraak.nl.
20. Hou P., Zou P., Low M.Y., Chan E., and Koh H.L. Structural identification of a new acetildenafil analogue from pre-mixed bulk powder intended as a dietary supplement. Food Addit. Contam. 23 (2006) 870-875
21. Reepmeyer J.C., Woodruff J.T., and d'Avignon D.A. Structure elucidation of a novel analogue of sildenafil detected as an adulterant in an herbal dietary supplement. J. Pharm. Biomed. Anal. 43 (2007) 1615-1621
22. Y. Hirama, T. Hayashi, A. Kanetoshi, Detection and determination of sildenafil in health foods, Hokkaidoritsu Eisei Kenkyushoho (2006), 56, 57-60 CODEN: HOEKAN; ISSN: 0441-0793 (2006).
23. Park H.J., Jeong H.K., Chang M.I., Im M.H., Jeong J.Y., Choi D.M., Park K., Hong M.K., Youm J., Han S.B., Kim D.J., Park J.H., and Kwon S.W. Structure determination of new analogues of vardenafil and sildenafil in dietary supplements. Food Addit. Contam. 24 (2007) 122-129
24. Gratz S.R., Flurer C.L., and Wolnik K.A. Analysis of undeclared synthetic phosphodiesterase-5 inhibitors in dietary supplements and herbal matrices by LC-ESI-MS and LC-UV. J. Pharm. Biomed. Anal. 36 (2004) 525-533